PHARMEXA Trademark
Trademark Overview
On Monday, October 29, 2001, a trademark application was filed for PHARMEXA with the United States Patent and Trademark Office. The USPTO has given the PHARMEXA trademark a serial number of 78090584. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 30, 2014. This trademark is owned by Pharmexa A/S. The PHARMEXA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Chemical products for use in the development of pharmaceuticals, vaccines, namely, therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use
Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine recipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA
Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotecnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely, in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research
General Information
| Serial Number | 78090584 |
| Word Mark | PHARMEXA |
| Filing Date | Monday, October 29, 2001 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, May 30, 2014 |
| Registration Number | 3319312 |
| Registration Date | Tuesday, October 23, 2007 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 4, 2003 |
Trademark Statements
| Goods and Services | Chemical products for use in the development of pharmaceuticals, vaccines, namely, therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine recipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA |
| Goods and Services | Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotecnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely, in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely, in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, May 30, 2014 |
| Primary Code | 001 |
| First Use Anywhere Date | Friday, June 1, 2001 |
| First Use In Commerce Date | Thursday, May 1, 2003 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, May 30, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, June 1, 2001 |
| First Use In Commerce Date | Thursday, May 1, 2003 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, May 30, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, June 1, 2001 |
| First Use In Commerce Date | Thursday, May 1, 2003 |
Trademark Owner History
| Party Name | Pharmexa A/S |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | 2970 Horsholm
DK |
| Party Name | Pharmexa A/S |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | 2970 Horsholm
DK |
| Party Name | Pharmexa A/S |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | 2970 Horsholm
DK |
Trademark Events
| Event Date | Event Description |
| Friday, May 30, 2014 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, October 23, 2007 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, September 19, 2007 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Wednesday, September 19, 2007 | ASSIGNED TO LIE |
| Tuesday, August 14, 2007 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, July 30, 2007 | ASSIGNED TO EXAMINER |
| Tuesday, July 3, 2007 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, March 26, 2007 | USE AMENDMENT FILED |
| Monday, March 26, 2007 | TEAS STATEMENT OF USE RECEIVED |
| Monday, September 25, 2006 | EXTENSION 3 GRANTED |
| Monday, September 25, 2006 | EXTENSION 3 FILED |
| Monday, September 25, 2006 | TEAS EXTENSION RECEIVED |
| Tuesday, May 2, 2006 | EXTENSION 2 GRANTED |
| Tuesday, May 2, 2006 | EXTENSION 2 FILED |
| Tuesday, May 2, 2006 | TEAS EXTENSION RECEIVED |
| Saturday, November 26, 2005 | EXTENSION 1 GRANTED |
| Tuesday, November 1, 2005 | EXTENSION 1 FILED |
| Tuesday, November 1, 2005 | PAPER RECEIVED |
| Tuesday, May 3, 2005 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Sunday, January 23, 2005 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Friday, September 10, 2004 | CASE FILE IN TICRS |
| Tuesday, April 15, 2003 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, March 4, 2003 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 12, 2003 | NOTICE OF PUBLICATION |
| Monday, December 30, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, November 18, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 6, 2002 | REINSTATED |
| Tuesday, November 5, 2002 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, June 25, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 28, 2002 | NON-FINAL ACTION MAILED |
| Friday, January 25, 2002 | ASSIGNED TO EXAMINER |
